Finance

Lists
Why is 600572 down 2.74%?
Dive Deeper
600572:SHA
Zhejiang CONBA Pharmaceutical Co., Ltd.
CNÂ¥4.26
-2.74%
(-0.12) 1D
Oct 15, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600572...
Open
CNÂ¥4.31
High
CNÂ¥4.36
Low
CNÂ¥4.23
Mkt. cap
11.10B
Avg. vol.
44.70M
Volume
58.35M
Dividend
3.52%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 24, 2026
P/E ratio
21.26
52-wk high
CNÂ¥5.17
52-wk low
CNÂ¥3.77
EPS
CNÂ¥0.20
Shares outstanding
2.67B
No. of employees
8K
Open
CNÂ¥4.31
High
CNÂ¥4.36
Low
CNÂ¥4.23
Mkt. cap
11.10B
Avg. vol.
44.70M
Volume
58.35M
Dividend
3.52%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 24, 2026
P/E ratio
21.26
52-wk high
CNÂ¥5.17
52-wk low
CNÂ¥3.77
EPS
CNÂ¥0.20
Shares outstanding
2.67B
No. of employees
8K
News stories
From web sources and news partners
About Zhejiang CONBA Pharmaceutical Co., Ltd.
CEO-
Employees7.83K
Founded1969
Headquarters-
SectorPharmaceutical industry
Websiteconba.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.62B
1.50B
1.91B
1.80B
Cost of goods sold
735.74M
751.67M
824.28M
786.71M
Cost of revenue
735.74M
751.67M
824.28M
786.71M
Research and development expenses
63.93M
78.49M
49.23M
62.51M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
635.30M
611.75M
751.80M
688.94M
Operating expense
718.20M
701.12M
825.90M
777.06M
Total operating expenses
1.45B
1.45B
1.65B
1.56B
Operating income
163.29M
45.06M
255.33M
231.98M
Other non operating income
-12.05M
-234.68K
-4.03M
1.79M
EBT including unusual items
268.24M
-51.57M
249.08M
225.65M
EBT excluding unusual items
167.94M
67.42M
266.37M
255.44M
Income tax expense
33.61M
53.06M
46.05M
40.26M
Effective tax rate
12.53%
-102.87%
18.49%
17.84%
Other operating expenses
19.42M
13.93M
22.15M
21.98M
Net income
230.43M
-109.67M
198.45M
179.32M
Net profit margin
14.25%
-7.32%
10.41%
9.99%
Earnings per share
-
-
-
-
Interest and investment income
20.29M
26.12M
4.64M
41.65M
Interest expense
-1.91M
-1.77M
-1.50M
-528.12K
Net interest expenses
18.38M
24.35M
3.14M
41.13M
Depreciation and amortization charges
-
-
-
-
EBITDA
246.75M
128.05M
338.33M
314.43M
Gain or loss from assets sale
6.34M
-4.89M
-
-522.49K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps